Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported financial results for the third quarter and nine months ended September 30, 2013 and provided an update on the Company’s business highlights.
Help employers find you! Check out all the jobs and post your resume.
